TELL is a pioneering health-tech company specializing in neurocognitive health assessment through innovative voice analysis technology. Our platform utilizes advanced machine learning algorithms to analyze speech patterns, providing early detection of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This approach offers a non-invasive, cost-effective, and highly accessible diagnostic tool, setting us apart in the field of cognitive health.What distinguishes TELL is our commitment to accessibility and accuracy. Our technology enables real-time monitoring and assessment from anywhere, making it especially valuable in underserved areas where traditional healthcare resources are limited. We focus on providing tools that are not only effective but also user-friendly for both healthcare providers and patients, ensuring that our solutions are practical at the point of care and beyond.Our collaborations with leading academic institutions and healthcare providers have allowed us to refine and validate our technology continuously, ensuring that it meets the highest standards of scientific rigor and clinical relevance. This has positioned us uniquely in the market as a trusted partner in the healthcare community, dedicated to improving patient outcomes and advancing the understanding of brain health globally. At TELL, we are driven by the vision that everyone deserves access to the best brain health monitoring and care, regardless of their location or economic status. Our technology bridges gaps in healthcare provision and opens new possibilities for the early detection and management of cognitive diseases.